Scholarlink

Purpose of Review <p>Irritable bowel syndrome (IBS) in children is a disorder of gut-brain interaction (DGBI) characterized by chronic abdominal pain related to bowel movements. This review aims to evaluate the clinical application of different therapies in pediatric IBS including current and new pharmacological and non-pharmacological treatments.</p> Recent Findings <p>While further pediatric data is needed in pediatrics to help optimize management, combination of pharmacologic and non-pharmacologic interventions are often used. Adult recommendations are published for the use of Linaclotide for IBS-C, tricyclic antidepressants for IBS-D. In pediatrics, CBT and hypnotherapy have been found to be successful in management of symptoms. Further evaluation is needed for the role of dietary changes and OMT.</p> Summary <p>Pediatric IBS may be difficult to treat and often requires both pharmacologic and non-pharmacologic management. There is no clear consensus for management of pediatric IBS and will often require implementation of adult recommendations for pediatric use. Gut directed hypnotherapy has been clearly shown to improve symptoms of IBS in children. Further studies are needed in pediatrics in the management of IBS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pediatric Irritable Bowel Syndrome: Current Understanding and Future Directions

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月19日

查看全文
  • Kathryn Hawa,
  • Khalil Zaydan,
  • Erik Andrewski

摘要

Purpose of Review

Irritable bowel syndrome (IBS) in children is a disorder of gut-brain interaction (DGBI) characterized by chronic abdominal pain related to bowel movements. This review aims to evaluate the clinical application of different therapies in pediatric IBS including current and new pharmacological and non-pharmacological treatments.

Recent Findings

While further pediatric data is needed in pediatrics to help optimize management, combination of pharmacologic and non-pharmacologic interventions are often used. Adult recommendations are published for the use of Linaclotide for IBS-C, tricyclic antidepressants for IBS-D. In pediatrics, CBT and hypnotherapy have been found to be successful in management of symptoms. Further evaluation is needed for the role of dietary changes and OMT.

Summary

Pediatric IBS may be difficult to treat and often requires both pharmacologic and non-pharmacologic management. There is no clear consensus for management of pediatric IBS and will often require implementation of adult recommendations for pediatric use. Gut directed hypnotherapy has been clearly shown to improve symptoms of IBS in children. Further studies are needed in pediatrics in the management of IBS.